Stock Events

Stock Events

CANNTAB THERAPEUTICS LTD 

$0
2
-$0-96.43% Monday 21:00

Statistics

Day High
0.01
Day Low
0.01
52W High
0.01
52W Low
0
Volume
2,000
Avg. Volume
0
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Apr 16
$2.16
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

29FebExpected
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
-0.02
-0.02
-0.02
-0.01
Expected EPS
N/A
Actual EPS
-0.0198

Financials

-1,262.72%Profit Margin
Unprofitable
2016
2017
2018
2019
2020
2021
230,363.83Revenue
-2.91MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CTABF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Charlottes Web
CWBHF
Mkt Cap22.6M
Charlotte's Web holdings produce CBD oil and extracts, competing with Canntab in the wellness segment of cannabinoid products.
Cronos Group
CRON
Mkt Cap962.94M
Cronos Group is involved in the production and sale of cannabis in various forms, a direct market competitor in the cannabis industry.
Tilray Brands
TLRY
Mkt Cap1.5B
Tilray produces medical cannabis products, directly competing with Canntab in the medical cannabis market.
Aurora Cannabis
ACB
Mkt Cap280.01M
Aurora Cannabis is a well-known producer and distributor of medical cannabis, competing in the same industry as Canntab.
Canopy Growth
CGC
Mkt Cap418.51M
Canopy Growth Corporation is a diversified cannabis and cannabinoid-based consumer product company competing across similar markets as Canntab.

About

Canntab Therapeutics Limited, a phytopharmaceutical company, engages in the research and development of advanced pharmaceutical grade formulations of cannabinoids in Canada. It offers oral dosage formulations of pharmaceutical cannabis, including sustained release cannabinoid formulations and pellets, immediate release cannabidiol formulations, modified-release multi-layer cannabinoid formulations, flash-melt cannabinoid formulations, and bi-layer cannabinoid tablets for treating sleep disorders, post-traumatic stress disorder, social anxiety, addiction, arthritis, general pain, pain management and appetite loss associated with cancer treatments, and addiction treatment therapy of opioids and other painkillers. Canntab Therapeutics Limited is headquartered in Markham, Canada.
Show more...
CEO
Mr. Richard C. Goldstein
Country
CA

Listings

0 Comments

Share your thoughts

FAQ

What is CANNTAB THERAPEUTICS LTD stock price today?▼
The current price of CTABF is $0 USD — it has decreased by -96.43% in the past 24 hours. Watch CANNTAB THERAPEUTICS LTD stock price performance more closely on the chart.
What is CANNTAB THERAPEUTICS LTD stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange CANNTAB THERAPEUTICS LTD stocks are traded under the ticker CTABF.
What were CANNTAB THERAPEUTICS LTD earnings last quarter?▼
CTABF earnings for the last quarter are -0.02 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is CANNTAB THERAPEUTICS LTD revenue for the last year?▼
CANNTAB THERAPEUTICS LTD revenue for the last year amounts to 230,363.83 USD.
What is CANNTAB THERAPEUTICS LTD net income for the last year?▼
CTABF net income for the last year is -2.91M USD.
Does CANNTAB THERAPEUTICS LTD pay dividends?▼
Yes, CTABF dividends are paid en. The last dividend per share was 2.16 USD. As of today, Dividend Yield (FWD)% is 0%.
In which sector is CANNTAB THERAPEUTICS LTD located?▼
CANNTAB THERAPEUTICS LTD operates in the Health Care sector.
When did CANNTAB THERAPEUTICS LTD complete a stock split?▼
The last stock split for CANNTAB THERAPEUTICS LTD was on April 20, 2018 with a ratio of 1:200.
Where is CANNTAB THERAPEUTICS LTD headquartered?▼
CANNTAB THERAPEUTICS LTD is headquartered in Markham, CA.